These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. Crowe SR; Miller SC; Shenyo RM; Woodland DL J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes. Wu Y; Kelly SH; Sanchez-Perez L; Sampson JH; Collier JH Biomater Sci; 2020 Jun; 8(12):3522-3535. PubMed ID: 32452474 [TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293 [TBL] [Abstract][Full Text] [Related]
10. Induction of lung CD8 Moriyama M; Takeyama H; Hasegawa H; Ichinohe T Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103 [TBL] [Abstract][Full Text] [Related]
11. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus. Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671 [TBL] [Abstract][Full Text] [Related]
12. A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses. Rudra JS; Banasik BN; Milligan GN Vaccine; 2018 Jan; 36(4):438-441. PubMed ID: 29248267 [TBL] [Abstract][Full Text] [Related]
13. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. Wiley JA; Hogan RJ; Woodland DL; Harmsen AG J Immunol; 2001 Sep; 167(6):3293-9. PubMed ID: 11544317 [TBL] [Abstract][Full Text] [Related]
14. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge. Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249 [TBL] [Abstract][Full Text] [Related]